SCHEMBL7410959

SCHEMBL7410959

CC(C)(C[CH]C(=O)N(C1CCCC(c2ccccc2)C1)C1(C#N)CCNCC1)C(N)=O

nearest known ligand 0.30

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
USP30 Q70CQ3 1/20 0.30
OPRM1 P35372 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7417579 0.84 DPP4 (0.31)
SCHEMBL7419573 0.83
SCHEMBL7417847 0.77 OPRM1 (0.38) OPRM1
SCHEMBL7416904 0.76 SNCA (0.35) OPRM1
SCHEMBL7417804 0.76 CTSS (0.32) OPRM1
SCHEMBL7416474 0.74
SCHEMBL7423675 0.74
SCHEMBL7420191 0.72 SNCA (0.34) OPRM1
SCHEMBL7412962 0.72
SCHEMBL7533076 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1218372-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES Boehringer Ingelheim Pharmaceuticals, Inc. (US) 2002-07-03 EP disclosed
WO-2001019816-A1 NOVEL SPIROHETEROCYCLIC COMPOUNDS USEFUL AS REVERSIBLE INHIBITORS OF CYSTEINE PROTEASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-03-22 WO disclosed